Entity
Description
  • Value proposition

    Grounded in nature, authored by AI

    Profluent is an AI-first protein design company. Founded in 2022, we develop deep generative models to design and validate novel, functional proteins to revolutionize biomedicine. Based in Emeryville, CA, we are backed by leading investors including Spark Capital, Insight Partners, Air Street Capital, AIX Ventures, and Convergent Ventures. To learn more about our mission to decode the language of life with AI, visit profluent.bio.

    artificial intelligence, machine learning, biotech, and gene editing

  • Profluent

    The next frontier is authoring new biology, and with AI, we have the power to write the future—creating solutions that transform medicine, agriculture, and beyond.

  • https://profluent.bio/
Catalyst interactions
Catalyst Type Tweets Articles
Gilead Sciences
Gilead Sciences
Pharmaceutical, Biotechnology, Biotechnology Research (Auto)
Gilead Sciences
Pharmaceutical, Biotechnology, Biotechnology Research (Auto)
Other

30 Nov 2025


Biotechnology Innovation Organization
Biotechnology Innovation Organization
Biotechnology Research (Auto)
Biotechnology Innovation Organization
Biotechnology Research (Auto)
Other

31 May 2025


NYSE
NYSE
Finance, Financial Services (Auto)
NYSE
Finance, Financial Services (Auto)
Other

1 May 2026


J.P. Morgan
J.P. Morgan
Bank, Financial Services (Auto)
J.P. Morgan
Bank, Financial Services (Auto)
Other

13 Jan 2025


Johnson & Johnson
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care (Auto)
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care (Auto)
Other

30 Sep 2024


Social network dynamics
Similar entities
BETA
Loading...
Loading...